Exhib i_t __3 June 19, Edited Transcript of Presentation of Jerome H„ Heckman, SPI Counsel at 1969 Meeting of SPI Food, Drug and Cosmetics Packaging Materials Committee Heckman I'm glad to see all of you here. I see there * are a number of new people here and I 11 try to take that into account as best I can in the way of providing background on some of the subjects I'm going to discuss. I'll have to ask some of you who are not new to bear with me. Those of you who have not been at every meeting since the formation of this Committee m 1956 will have some difficulty in picking up the threads but we'll do our best. I want to cover a couple of matters quickly before I get into the meat of current problems which, of course, relate to the National Conference on Indirect Food Additives "aftermath '--the name we've giver, this subject--and the so-called Ramsey proposal. There have bee:-, some changes in the FDA Staff. Willard Orr, with whom some of you have probably had occasion to deal in the Petitions Control Branch, has now moved into the feed additives field, and is no longer available to help Bill Randolph with the handling of Food Additive Petitions.* Bill Randolph is, of course, feeling quite swamped and petition processing is suffer­ ing along as usual Another m passing item which some of you may have been reading about is the fact that FDA is expecting * Since the meeting, Mr. Orr. Mr. William H. Morgan has replaced ASI-PR 0000950 very rr. ir moi ■ require'.'1 Over the ve,rs, ■■■-'■ <. ^ vlr 7tH what is the fete add i1 :' or P VC resins, r wK; t-. he has followed * he pro,-" of a copy of our Me v-, i tv :t extra copies of the tano l VL ( for that- purpose. ■ ryiire r '.ays -euppiy-qiiiv-o cm One re-isr 1 r‘" ‘ ir t"i = oa. ■, because Mr, Ra'-dolpt -ova advised us --e-t 1 ’ o ; a s sea FDA s Division of Chem i s t t y and Fold T-hoy to i i / to develop some sort jf pi V o::o * n,-r • _•■ d he pa -- ->d out to those who arc t;~ i ah Ol, t ■ i ; i u S ome Ot her relating to a stabi'izei , on e,'r •_ oxidant , adjuvant proposed for js-,; o 11 a 1 p'-lo- ■'is, - r at east with a broad spectrum if n 11 v"" ' ' s ' a,r ‘AC ' : 0 a or . : : l ' DA , single o^e . Thir- are t m >......... impor come to us e-d sa u •'-<> -■•noi' izer or antioxidant and v r- *■ r : - '■ i- ■■ b re degree of success w 11 ^ a * m-h": e ei s e ow d i we q o abou t filing d pe t i t : ? P ■ d ■ -- o arises as to how on -h >'xu i v • oh d - .it''oat in order t j sat is rv ■' d ; ■ * will be safe to u a - 1■■ , * *' ■ ; ■ : o 1 osort of qurst ir- t ’• o-1 ■' 1 - - r _ = ■ - ' • ■ r■ qoe- oy 1 a r r- \ y Division so tn„f yyo of Chemist r / c ■ r- - -d ’ a - ’a • , i with a proto'’o' test rhis ad ] uva," t wit1ought to be f"ou;|1', '-os' l that we cav give von one-. Asknq for s■, one are two v,,nt : v dif feasy j ob r k • o e > ' -i it T d -j i 7 ,i nt o a -,: ; -a ; 'J on ,, t r r ’ , o e---er ' t OpL q ■ ■’r 5‘ ASI-PR 0000952 romtf up - i " . , ■ ‘; : • cjursi', —1 ‘ ;m r W it'": L - b -"'1,:: : ■ ■ : Sr ,if f * o ^ r ,■ L f vr w oe ■ b in o i ; ’ hr- ■ or 1 ■ i= ■ ■ t~ i_ that. SRI n - ■ . would ■ p- ■ -■ you won Id sqrf- o ; - ■■ ■ be mu eh better f o .. s inak<= suqq^st i r-o h* : ,r rather <-h ~ omro l r t r . - -wy ■- e; =■ oomm l f t oe a id , tO (1 1 ?' o s t.-: ' ■ s one of br - . ■ i. p = f-_.o i ■ - , : o f e on , • ■ o-- ikp r^sp ord t ■1 '■be r epor t. ed 1 ook r o t of !icb*-"-'t t t1 e of nour oe. i. f w ■ - • '< _ ' 1 "\ r / ■? i - e-- b- br .. o them a 0 *' e Of no L ' -l:, • - ’ o r},T< , : L' i L f L e.b f ' ' _ *5 V.M o' e b - ’ u o ; o- r ^ JO ■\ Vl't P t n P r ASI“PR 0000953 FD4 hax M w l t h i" r that -xb _'C , atisor'r s * ", pub;i- made pub ! 1'” hear mgs : V f- likely t. o p wou : d be Ov‘ ■ heard on t- K , .V' 1 Oc matter a ■“ n To q i ' mcnt Lon , He r1- -j r asked Th, f r s of' s u m e r - r r i o • * e d Ta a 'I l at pu - from pr i va i «' - I ■ £? r ex* -■ •' t , 1 • ^ ‘ m r ■ z age" qy c'viy.ei; be groat : (O quest L 0" 'A". : 1 to qivr ' \odet 1 s VOU vVi ''m-y.’-iet " r > a . d■“ >- i m irb 1 i1 t ! ' r <■ ‘ ■ ■ ' j g o i " g to f i - 0 summer l- t'"e -vu- '-’ederu : Trade 11 ;r- ■ ■ c omm it e Ls r . r. ■ 1 a d U S t f y a d ' .■ yy fur qt i o" s .s rd L - v o ! vcd i ■■ mak : "y i u t ^ • .J t .• j~ •, a ■' ' pt ru'^-s - ? j f t h- ASI”PR 0000954 V L ■= V' 3 ' d J f f-' ” bOr"0O“ . l'' ; ! ■ ' '\ 1 V, ■ ‘ ' ‘ • ; 3 FDA <-i r how t, h a " “; i r'5 , ')'■ 7 • pro: A - 3. - w- Aq^"‘’p a thp a q c 2. " u" ■J rt i r 1 F s ■t pr oo’es/ws f 1 ow of f oi m -1 a-d j.' aqe-’ p y rs 1 b" ;h withheld f r -n y s u oh w 11 h1- o' o i q ’ '0 b < _ - i f 5 :of PL Op 3 5 0Cl -- 1; , 3 O' raak l oq l* - ' '0 ‘ i ■■ field- F'- -o'-pv' a k h q - '• 0 '<■ f r ' h ,, , , : l • AJ d lr -r ■ a■ d "01 mo ’ b'- 31 = r •1 r- f l ■1 q *" O see '0 , ’ .■: ; q ,o . l o fr icjue s ■ . a - d : or t ead i -q - - i ■-! -' a a fo• -r ad h , o . a1 ■ b mi t. 1 " oC it.' . H ow -'~v!a 0 ' 7 ; '• • c , ” ad J l f ive or' " i 0 ' 0 * -/Of pr 0r 1 ” Vs o'dur-'; = i" i ..it + ) r ‘ hi .-d-: ‘'ommission be 1 ] T p d ■ S - 1 f_! ' ‘ 1 h * ■ r r ■ ■■ 0 ■ •.'•■ de.t f -Mr s for ro s o _ t-■ -ew r- b v ' ' 1 - -' '->£ o nr 1 raised l^ t ; , A the qims1 i eja 3 FI'p - ' n-- e t. i nq a ■ -d received acor^, s i.aer i1 c !ead to . * t he or / a basis -- " st ’■ a f ;of 11 r' or or r o 3" C t V l-■ ;v - ’n rv- f ‘' f r J , f ., > i t- * ■ 1 t ' J '' ~ t F t ”F if - j; . ■ of ■ on- i 1 ■ , e r o“" ' 01 it l ~.i: . r = , - p apq ip 1 r ea : 1 v on iqh t n.oijose1. ’ provides ; n 01 1 on , mops ' ASI-PR 0000955 7 Another Kennedy Subcommittee inquiry many of you will be interested in is 'Do you belive that the agency's decision making procedures operate with reasonable speed, considering the interests and issues involved? Assuming that faster processing and decision making are desirable, how could they be achieved?" We've given FDA our views on this question many times so we would be interested in seeing how the agency answers the Kennedy question if we are ever able to determine the answerThe last question that I think might be of some interest is one that asks: What procedures does the agency have for assessing the quality and efficiency of its own performance? How often and in what manner does the agency review the continuing relevance of its mission, goals, priorities, procedures and structure? In what ways could such review be stimulated?..,' Fascinating set of questions. One sort of a separate type question posed is whether the staff quality is adequate to handle the complex and sophisticated issues presented to the agency. There;s really only one answer FDA couLd give to that question if it's going to tell it like it is" but I doubt if that answer will be given. Does anyone have a question up to this point in my report? We usually do this by simply allowing interruption whenever you see fit so those of you who are new, chime right in. Question: Who is Bill Randolph? Heckman: Bill is m the Petitions Control. Branch of FDA and is technically titled a 'Food Additives Officer' which really doesnt' mean anything. From our ASI-PR 0000956 3 - point of view, and as a practical matter, Bill Randolph is the staff man who handies all of the administrative processing of incidental, food additives petitions. When he gets help there will be another mar with him. They serve as what some might call coordinators in receiving petitions, circulating them within FDA and notifying petitioners regarding questions that arise, or petition status. Any letters you might receive on a petition would probably come from Mr. Randolph or his co-worker in the Petitions Control Branch. Questionisn't Mr. area? Buckley also working in this Heckman; Right, but Buckley has been and still working on direct food additives problems only. is Question. Do you have any indication at all, when Spiher will be retiring? V Heckmans No. Spiher, for those of you who don't know, has a. position that's technical, just below McFarland who is over-all. Chief of the Petitions Control Branch, McFarlard is really on top of Buckley, Randolph, all of the people that work on petitions Now, let me get into this major situation that we really have to deal with It relates to the Ramsey proposal, but, for the sake of putting things in perspective, I want to take a few minutes to review the backgr ound. Actually, l think it's fai.r to say that the genesis of the Ramsey proposal was probably an American Chemical Society meeting arranged by Ken Morgareidge way Since this report was given, Mr Spiher has been on ''special assignment' to the Consumer and Environmental Health Service, FDA's parent entity. He is, thus, not presently active on food additives matters. Whether he will return to basic FDA *_/ ASI—PR 0000957 9 back in 1966, Ar that meeting, somewhat to FDA's surprise, although I really don't know why, a number of papers were given that literally took the agency to task in depth on the indirect food additives question It was perhaps the first time tba* there was an entire series of papers publicly indicating severe criticism of the way indirect food additives are regulated, * I gave one of those papers, Jack Frawley gave another. There were a series of other papers-George Ingle gave one--that were more technically oriented than critical, Don McCollister of Dow gave one, two men from Eastman discussed radioactive tracer data. It was at that time that the so-called Frawley Proposal" was first, advanced. What Jack did was to comment on the fact that FDA was doing a very poor job on in­ cidental, additives by, in effect, over-regulating,' The net result was a waste of scientific time and expertise. As a means for delimiting petition film-'g he suggested that FDA eliminate the need for regulating components of packaging materials which were put into the package at a level of less than 0,2 percent, so that if you made a substance that was going to be used at a level of less than 0,2 percent m a food package, and the substance was not a heavy metal, a pesticide or a known carcinogen, FDA should permit its use without requiring the filing of a petition for issuance of a regulation After 1.966 and despite what had been said in these papers, nothing really changed, at least not right away. There was a lot of alleged internal discussion at FDA about the feasibility of the Frawley Approach , and generally about the feasibility of doing something about indirect food additives, but nothing really moved, because there wasn't enough effective pressure being brought to bear on the agency to make things move ^/(Cont.'1 work again his present work. is unclear, as is the exact nature of ASI-PR 0000958 -:o- Thereafter, approximately in August of 1967, it was suggested to a Congress iona ] Committee*/ that the indirect additives field was being badly mishandled. The reason that the situation was brought to the attention of that particular committee was because the Chairman of the Committee was and is Con­ gressman John Dingell. of Michigan, Congressman Dmgell had been on the original, committee^*/ that handled all of the legislative work on the Food Additives Amendment,, and had chaired many of the hearings. The Congressman expressed an interest in the interpretation that FDA was giving to the Food Additives Amendment, particularly that portion of the statutory language which provided the basis for FDA’s authority to regulate incidental additives, (i.e. any additive that "may reasonabl.y be expected to become a component of foods }So, at his request, a series of questions were prepared that were submitted to Dr James Goddard, then Commissioner of FDA. at a Con­ gressional hearing. Dr. Goddard was asked to have answers to the questions within 30 days. FDA set about attempting to prepare the answers to the questions, but had some diffL.'ulty, to say the least, because the questions were reasonably searching. Finally, because they couldn't really answer a lot of the questions without conceding that the incidental food additives situation was in a state of confusion, they advised Congressman Dingo 1.1 that, as a partial response to the questions, FDA was going to call a national conference on indirect food additives and that the agency would report back to him within 30 days after the conference. J/ The House Select Sma 1 1 Business Subcommittee on Regulatory Agencies, * */ The House Interstate and Foreign Commerce Committee. ASI-PR 0000959 Industry was given about a, month's notice on the conference and we were totally ur.abie to get any extension. Before anyone knew what was going to happen, FDA had sent out a meeting notice, and had laid out a program which was rather vague. On the one hand, FDA was counting on industry to participate, but on the other hand it had arranged things so that industry would have little, if any opportunity to make a strong, coherent presentation in opposition to the manner in which incidental additives were being regulated. In any event, under the auspices of SPI, we got together representatives of the trade associations representing the main packaging industries that we knew had been called to come to the conference on indirect food additives. We had two pre-conference meetings and all agreed on the basic industry position that should be presented at the conference. As a result, contrary to some of FDA's expectations, we went into that conference fairly well prepared. One of the things that we all recommended strongly was the establishment of a Government-Industry Advisory Committee. There was a great deal of debate on this subject at the conference, some of which became quite heated at times. There was some strong resistance to a Government-Industry Advisory Committee by FDA re­ presentatives which was not entirely clear. If nothing else, I think the conference served a useful purpose in putting ’'on the record 1 some of the points of view of industry. By the way, I mentioned this at the last two meetings but I wil.1 mention it again, I still, have transcripts of the proceedings of the National. Conference on Indirect Food Additives, so if any of you who have not yet requested and received one would like to have a complete transcript, which has a great deal of background information of value, generally, by ail means drop me a note, and we will be happy to send you a copy. ASI-PR 0000960 r - .■ b--k a 1 f of your .■ 0-9 -* .n FDA -a ayo-.^y O" some proposed ?i :-"du,a had published. "‘"'2=0 Pr •- ■ ■ r" drafted by Mr Alan SpjJ'or m-d comments because. q>.ite fra i! o, we we ; ■' joking for anything at. ail * -re w u. : 1 u-. n/.b-'im1- a r-.a-s to place industry's va'v“ ebwjf t Ke -. fr: 111 .-dditiveregulatory situation w- •= f o 1 ro~otd T " proposed regulations are still p-'riw'y -■_? d -.w bc'~u promised that they will rot be f r r- ' o t. r v "ig ificsmt part tn rsse- -m: , 'JwO I. o rt ;; if ’ -jS.vS 1 3 lhat t oxic o 1 oq i s t s haw n:mr' - o th.: • - 1 y s i o - t l,at 0 ppm of anything in tl-e diet , c t ^r fu r‘ ■ v : f tl'e t :x i on 1 og l s t s 1 ASI-PR 0000961 rime and ad?ntio" to establish safer'/. T”rf is ar easy way fa paraphrase what it tl-'■ s - - rhi'tk The problem, of coursp, as far as t'ae food packaging industries are ronrsr'td, is in trying to convert. 0..! ppm in tha diet to some meaningful, figure in a package or a food. To analyze for such an, amount, you would measure the daily intake of a qiven type or generic category of food awd then determine how much of 'X" substance will be m that total, daily amount, because parts per million really is a relative mathe­ matical concept. . Now at the last Committee meeting, m my report, f spelled out for you the basic "oncepts that we expected to be put forth in FDA s anticipated pro­ posal. The FDA proposal, 1 advised, wou'>d be aimed at amending Sem nn ; 2 i . 2 T 0 0 'if the Food Additive Regulations, which, unfortunately, is often referred to at the ''Good Manufacturing Practices" Regulation for incidental food additives, It's a *oos* term but the reason for that is that Section 121.2500 is a genera! regulation that precedes all of rhe specific; Food Additive Regulations, and talks, i”> general t=rms, about what is deemed to be good manufacturing practice ir, the use of a-, incidental food additive For examp5'.-. that's the section t^at says you sha ! ! r.ot use anything that v; I I give a taste or odor problem m foods We advised at the lust session that- FDA would come up with a proposal to .-mend that Section and ’could use it as a means to exempt certain’ kinds of things from the necessity for the f i ! i'-g of food additive pet, it ions At our Last meeting l fold you about some of the details of the pro­ posal and what they were supposed to be. W^at I told you was essentially correct except that FDA made two changes subsequent to my last report. The basic differences between what I told yon and the ''Ramsey ASI-PR 0000962 proposal,' wb : cV, has f- ow bee” i f ;rn.i i y circulated to the packaging industries cor e orom ■='. t , are twos ( U instead of using the "economic poisons definition m the Proposal, paragraph -'d'; (5- says that certain specified substances, i.e. heavy metals and >-a r c 1 r-ogens, will not be exempt under any circumstances, and other substances that have been demonstrated to produce toxic reactions when present at levels of 40 ppm or less in the diet of man or animal wlII not be exempt, and (2' the -ew "no migration” phraseology in the proposed paragraph (d'; (5) O.kf. oar"- t y^r mill ion criteria set forth in the Ramsey proposal, So the points I ve mentioned the mes we will be discussing with FDA. p:e will r.ot bo arguing about whether FDA should give letters or, "no migration situations or any of those otr^r questions, but one of the things I really want to know from this committee today is what other points you think should be argued, perhaps on behalf of SFI mst-'ud of or behalf of the food packaging industry as a whole. • Question: Could you please explain a ,.itr;e more about the basis for the position rhat no safety problems occur when most components are present in a package at a level of 0.2 per cent or less? Is there any data supporting that conclusion? Heckman; .7 d like Bob Miller, if he will, to explain some of the background behind this Pruv].ey theory. .Mil ler If anybody has any data o- n 'tool, migrations of components or muter i-;: • i - t j feeds we would certainly like to have it to include m this document we're going to give to FDA, to support our position. In Jack Fruwley’s ACS paper, end subsequent rewrites, he used the data Hercules has on ronr paper migration into food, in addition to anofr.er ore that Hercules had published sever'j! years ago on p ias t i'-iz er s for PVC, to show how the 0 2/ of th-': tot-.1 pa-'kuqe ma­ terial for a component limit would be cased without safety concerns so long as the component was not a heavy metal, pesticide, or know-' carcinogen. The rosins and PVC data are all we have so if ooyo-e has any more ASI-PR 0000967 - :9 - or better data op. actual migration to foods, we would certainly like to have it as back-up information. Questior: Do you think FDA will accept the 0.2 per cent level., or less, theory? Heckman: This is a personal opinion, it s certainly not Jack Fravley's, and mavbe not the opinion of our Inter-Industry Committee, and it certainly won't be reflected in our negotiations with FDA. but if 1 had to give odds I wouid sav that our chances of getting the 0.2 per cent concept adopted are not as good as our chances of getting FDA to adopt the 0.5 ppm concept. Question; What's the possibility of getting a re­ vision of the generally understood list of heavy metals that will not be exempt from regulation under the Ramsey proposal? HeckmanNot very good, due l- pari to the fa^t that heavy metals are naturally present in the diet already, so its no kind of argument with FDA at all to point out the unavoidable presence of substances in "natural" foods. What they say in response to that argument is 'we agree that those things are present in the diet and there’s nothing we can do about that, but we are not going to permit an increase- to the dietary background of those metals and, therefore, the only way to get them cleared ls by the pet it lop route." In other words, heavy metal.s will not be exempt from regulation except in those generally accepted applications where no petitions would be required, such as in repeated use" and "barrier1 situations. Question. Would you care to comment on what effect, if any, the Ramsey proposal will have on FDA's present policy of refusing to issue 1 no migration letters? ASI-PR 0000968 20 Heckman: Well, that's a point we are going to try to clarify. T thmk, but I can t guarantee •'his, that if we end up with a proposal that's workable, then FDA will probably begin writing letters of concurrence that are worthwhile again. Thus, for example, if FDA accepts an 0.5 ppm criteria and you submit a set of data to FDA that shows that you have a test method that is sensitive to 0,5 parts per million, and that you have no migration at the level of the test method sensitivity, and it is therefore your conclusion that you don't have a food additive, I think that FDA would then send letter^ agreeing with such conclusions. However, I can't guarantee that, and I think the consensus is that we should not raise that subject with FDA at this time. That's a subject we can go back to at another time, after we've accomplished something substantial with regard to the proposal, itself. Question? Am i right in assuming that the Ramsey proposal implies that FDA is willing to agree that with certain specified exceptions, anything that is added to a food contact surface at a level of 0 05 ppm, or less, is safe? Heckman; Not really, all "DA is really doing is agreeing not to ask you to demonstrate safety or anything else if you've got a material or -ompo'-ert that is not going to get into food at any level higher than 0*05 parts per million. Disregard whether it is safe or not. FDA won't ask you to demonstrate that it's safe by means of a petition and ultimate regu la t io"> if you're dealing with something that vou put mho the food contact surface at a level of ]eS3 than 0-05 parts per million. We want them to raise that thrcshhold level to 0,5 parts per million but, in any event, it's not really a question of safety in the f inn . analysis, it's a question of what you have to file petitio’-s for. ASI-PR 0000969 I must apologize for having spent so much of the Committee's time in discussing these matters, but I think you will agree that the subject matter is not the kind that lends itself to systematized pre­ paration and discussion. In any event, I do hope you have found our "information exchange of the past hour or so helpful and informative. Thank you. Editorial Note; As lengthy as it is. all Committee members should understand that the foregoing "edited transcript does not. purport to cover the discussion at. the meeting in full. This is due in part to our attempts to make the transcript reasonably coherent, a-'d lt part to the fact that some portions of the tapes made at the session were simply incomprehensible. You have our apologies if one of your questions, one of special ro-cern to you is not reflected herein. JEFOMF H. HECK.MAN ASI-PR 0000970